COMMUNIQUÉS West-GlobeNewswire

OPS Code Established for Peripheral Vascular OCT Imaging in Germany
20/02/2018
REDWOOD CITY, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that the German Institute for Medical [...]
Soleno Therapeutics Announces Successful End-of-Phase II Meeting with FDA for DCCR in Prader-Willi Syndrome
20/02/2018
Minutes Confirm Alignment on Soleno’s Planned Phase III Clinical Trial Soleno In Process of Initiating Phase III Study REDWOOD CITY, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a [...]
Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent
20/02/2018
BRIDGEWATER, N.J., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the United [...]
VitalHub Selected to Showcase WellLinc Solution Among 40,000 International Attendees at HIMSS 2018
20/02/2018
TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) has been selected to present its proprietary “WellLinc” EHR interoperability solution at HIMSS 2018. The Healthcare [...]
Actinium Pharmaceuticals Announces Product Showcase and Other Visibility Extending Activities at the BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations
20/02/2018
Actimab-MDS to be featured in a Product Theater on February 21 st Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s [...]
Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress
20/02/2018
PHILADELPHIA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today corporate and [...]
NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer
20/02/2018
SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ) today announced that the National Comprehensive Cancer Network (NCCN) has updated its medical guidelines for prostate cancer [...]
Horizon Discovery Group plc: Capital Markets Day Date Change to 5 March 2018
20/02/2018
Horizon Discovery Group plc Capital Markets Day Date Change to 5 March 2018 Cambridge, UK, 20 February 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and gene [...]
Horizon Discovery Announces Leadership Changes
20/02/2018
Horizon Discovery Announces Leadership Changes Cambridge, UK, 20 February 2018 : Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company", or "the Group"), a global leader in gene editing and gene modulation [...]
Obalon’s Audit Committee Investigation of Whistleblower Allegation Finds Complaint Meritless
20/02/2018
SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) today announced the Audit Committee has completed its investigation into a purported whistleblower complaint and concluded that the [...]
Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases
20/02/2018
Collaboration to include development of gene therapies consisting of vectors to deliver monoclonal antibodies to the brain directed against tau Voyager to receive $69 million upfront payment and potentially up to $155 [...]
Blood donors urgently needed to meet patient needs leading up to spring break
20/02/2018
OTTAWA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services has issued an urgent call for Canadians to give blood. More than 35,000 donors are needed by Spring Break to ensure all patients continue to have access [...]
Discovery Point Retreat Offers Drug and Alcohol Rehabilitation in Texas
20/02/2018
WAXAHACHIE, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- In an ongoing effort to help combat the substance abuse epidemic affecting the United States, Niznik Behavioral Health introduces Discovery Point Retreat, a drug and [...]
Melinta Therapeutics’ Commercial Partner Eurofarma Laboratórios Submits Marketing Authorization Application for Delafloxacin in Argentina
20/02/2018
NEW HAVEN, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]
Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders
20/02/2018
Wave to receive at least $230 million, including $110 million in upfront cash, $60 million in equity investment and at least $60 million in research support Takeda to receive option to co-develop and co-commercialize [...]
Urgent besoin de donneurs d’ici la semaine de relâche
20/02/2018
OTTAWA, 20 févr. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang lance un appel urgent au don de sang. L’organisation a besoin de 35 000 donneurs d’ici le congé du printemps pour s’assurer que tous les patients [...]
AxoGen, Inc. to Present at Canaccord Genuity Musculoskeletal Conference
20/02/2018
ALACHUA, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, [...]
Amunix announces XTEN® and ProTIA technology licensing agreement with Celgene
20/02/2018
MOUNTAIN VIEW, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, is pleased to announce [...]
Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research
20/02/2018
MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Pages